ISRCTN00049084已完成不适用
A double blind randomised cross-over trial to assess the value of screening an adult population for hypothyroidism
Queen Mary University of London (UK)0 个研究点目标入组 60 人开始时间: 2009年2月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Women aged from 35 - 79 years, men aged from 65 - 79 years
- •2. Attended general screening at BUPA Wellness Centres between 1 January 2006 and 15 September 2007
- •3. Detected with thyroid stimulating hormone (TSH) greater than 4.0 mU/
排除标准
- •1. People under current clinical surveillance for thyroid disease, or taking thyroxine, or having known pituitary or adrenal disease
- •2. People known to have coronary artery disease
- •3. People with any illness that in the doctor's opinion warranted exclusion from the trial
- •4. Diabetics taking insulin or oral hypoglycaemics, or people taking anticoagulants (warfarin or phenindinone)
- •5. People taking certain drugs that affect the serum concentration of TSH or free thyroxine
研究者
相似试验
进行中（未招募）
不适用
Double blind randomised cross-over trial to assess the value of screening an adult population for hypothyroidism - CROSS OVER RANDOMISED TRIAL OF ADULT HYPOTHROIDISM SCREENINGEUCTR2005-003464-30-GBQueen Mary, University of London
已完成
不适用
A randomised double-blinded cross-over trial comparing betamethasone valerate and tacrolimus ointment for the treatment of moderate to severe atopic eczemaAtopic dermatitisISRCTN27411543Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)100
已完成
不适用
A study to assess the effect of coffee on the ability to perform simple physical and mental exercises in healthy individuals during the post-lunch periodCTRI/2019/02/017763Dr Suganthi S16
尚未招募
不适用
EFFECT-FD: Effect of adding bezaFibrate to standard lipid lowering therapy on non-Fasting CholesTerol in patients with FamilialDysbetalipoproteinemiaFamilial Dysbetalipoproteinemia Familiaire Dysbetalipoproteinemie (dutch)NL-OMON29530niversity Medical Center Utrecht20
已完成
4 期
A randomized, double blind, cross-over trial to study the effects of adding bezafibrate to standard lipid lowering therapy on postprandial lipids in patients with Familial Dysbetalipoproteinemia <br>Familial DysbetalipoproteinemiaFredrickson Type III hyperlipoproteinemia10013317NL-OMON43954Academisch Medisch Centrum15